Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Turing Pharmaceuticals to Retain Daraprim List Price, Offer Discounts to Hospitals

November 25, 2015 9:59 am | by Matthew Dennis, FirstWordPharma | News | Comments

Turing Pharmaceuticals announced that it will retain the current list price of Daraprim (pyrimethamine), whilst offering reductions of up to 50 percent for hospitals. Turing has faced recent criticism after the cost of the toxoplasmosis therapy jumped from $13.50 a tablet to $750, with CEO Martin Shkreli suggesting that the company would address the issue. Read more...


Allergan, Rugen Therapeutics To Collaborate on Treatments for Autism, OCD

November 25, 2015 9:41 am | News | Comments

Allergan plc, a leading global pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology company focused on the development of novel treatments for unmet CNS disorders and funded by the F-Prime Biomedical Research Initiative (FBRI), today announced that they have entered into an exclusive collaboration. Read more...


Immune-disorder Treatment in Mice Holds Potential for Multiple Sclerosis Patients

November 25, 2015 9:27 am | by University of Florida | News | Comments

A University of Florida Health researcher has found a simple, rapid way to treat an immune-related disorder in mice, an approach that could eventually help multiple sclerosis patients after further research. Read more...


Scientists Reveal Potential Treatment for Life-Threatening Viral Infections

November 25, 2015 9:24 am | by The Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown for the first time how a previously unknown process works to promote infection in a number of dangerous viruses, including dengue, West Nile and Ebola. Read more...


An Indictment of Ebola Response

November 25, 2015 9:17 am | by Harvard University | News | Comments

An independent group of 19 international experts, convened by the Harvard Global Health Institute and the London School of Hygiene and Tropical Medicine (LSHTM), today issued a scathing analysis of the global response to the 2014-15 Ebola outbreak in West Africa. Read more..


Non-Disease Proteins Kill Brain Cells

November 25, 2015 8:17 am | by Trinity College Dublin | News | Comments

They made their comparisons in cells and animal models, and via experiments that studied electrical ‘brainwave’ responses in these cells. Read more...


Mylan Launches Generic FazaClo Orally Disintegrating Tablets

November 25, 2015 8:16 am | News | Comments

This drug is used for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. Read more...


FDA Approves Lilly's Portazza for Specific Type of Lung Cancer

November 25, 2015 7:45 am | News | Comments

Portrazza has been granted Orphan Drug Designation by the FDA. Read more...


"Good" Mozzie Virus Might Hold Key to Fighting Human Disease

November 25, 2015 7:30 am | by University of Queensland | News | Comments

Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes. Read more...

Global Gaucher Disease Treatment Market Value Will Reach $1.16B by 2024

November 25, 2015 7:15 am | by Edit Kovalcsik, Ph.D., Analyst, Cardiovascular and Metabolic Disorders | News | Comments

This increase can be attributed to continued efforts by Genzyme and Shire to raise awareness of such a rare condition as Gaucher disease. Read more...


Why Poo Transplants are Nothing to Be Sniffed At

November 25, 2015 7:00 am | by The Conversation, Tim Spector of King's College London | News | Comments

Five years in the future we could be popping capsules to cure us and reboot our healthy gut community made up of our frozen poo we stored when we were healthy. Read more...


Experts Foresee Big Premium Increases for Medicare Drug Plan

November 24, 2015 12:21 pm | by Ricardo Alonso-Zaldivar, Associated Press | News | Comments

With time running out on open enrollment season, many seniors are facing sharply higher premiums for Medicare's popular prescription drug program. The reason: rising drug costs have overtaken a long stretch of stable premiums. Read more...


Investigational Drug May Prevent Life-threatening Muscle Loss in Advanced Cancers

November 24, 2015 12:14 pm | by Ohio State University Medical Center | News | Comments

New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. Read more...


Research Team Describes Novel Tumor Treatment

November 24, 2015 12:03 pm | by Virginia Tech | News | Comments

In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos in Scientific Reports has been published. Read more...


Yin and Yang of Serotonin Neurons in Mood Regulation

November 24, 2015 11:51 am | by Columbia University | News | Comments

Low levels of serotonin in the brain are known to play a role in depression and anxiety, and it is customary to treat these disorders with medications that increase the amount of this neurotransmitter. However, a new study carried out by researchers at Columbia University Medical Center (CUMC) suggests that this approach may be too simple. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.